DCC plc (DCCPF)

Theseus Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul 15, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	6,036	6,579	7,191	5,764	7,684	8,541
Market Cap Growth	-9.57%	-8.52%	24.77%	-24.99%	-10.03%	36.70%
Enterprise Value	7,781	8,634	9,207	7,639	8,649	9,525
Last Close Price	62.38	65.27	67.69	50.09	80.00	76.76
PE Ratio	22.62	24.66	17.45	13.95	18.71	21.19
PS Ratio	0.26	0.28	0.30	0.21	0.33	0.46
PB Ratio	1.47	1.61	1.79	1.52	1.97	2.29
P/TBV Ratio	7.08	7.72	-	227.69	21.59	14.07
P/FCF Ratio	12.70	13.85	11.58	10.90	22.71	10.98
P/OCF Ratio	8.03	8.75	7.89	7.09	12.94	8.52
EV/Sales Ratio	0.33	0.37	0.39	0.28	0.37	0.52
EV/EBITDA Ratio	6.99	8.80	9.71	7.83	9.14	10.52
EV/EBIT Ratio	11.87	13.59	14.70	11.59	13.22	15.06
EV/FCF Ratio	16.38	18.17	14.83	14.44	25.56	12.24
Debt / Equity Ratio	0.73	0.73	0.74	0.88	0.80	0.78
Debt / EBITDA Ratio	2.76	2.76	2.86	3.11	3.02	2.92
Debt / FCF Ratio	6.28	6.28	4.79	6.28	9.23	3.72
Asset Turnover	1.92	1.92	1.95	2.29	2.02	1.68
Inventory Turnover	15.52	15.52	14.58	17.02	17.25	17.61
Quick Ratio	0.81	0.81	0.79	0.88	0.95	1.12
Current Ratio	1.51	1.51	1.18	1.28	1.37	1.40
Return on Equity (ROE)	7.02%	7.02%	9.21%	11.51%	11.49%	11.54%
Return on Assets (ROA)	3.28%	3.28%	3.21%	3.43%	3.54%	3.60%
Return on Capital (ROIC)	5.58%	5.58%	5.49%	6.00%	6.13%	5.87%
Return on Capital Employed (ROCE)	8.40%	8.40%	8.60%	9.00%	8.60%	9.10%
Earnings Yield	4.42%	4.06%	5.73%	7.17%	5.34%	4.72%
FCF Yield	7.87%	7.22%	8.63%	9.18%	4.40%	9.11%
Dividend Yield	4.36%	4.08%	3.67%	4.62%	2.89%	2.87%
Payout Ratio	95.57%	95.57%	57.87%	53.24%	51.41%	49.05%
Buyback Yield / Dilution	-0.19%	-0.16%	-0.10%	-0.07%	-0.09%	-0.14%
Total Shareholder Return	4.17%	3.93%	3.57%	4.55%	2.80%	2.73%

Updated Nov 12, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.